Advertisement
KMDA vs SIGA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and SIGA is a Hold.
KMDA in downward trend: 10-day moving average crossed below 50-day moving average on October 13, 2026
The 10-day moving average for KMDA crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KMDA as a result. In 64 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for KMDA turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 34 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
KMDA moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Aroon Indicator for KMDA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 68 cases where KMDA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The 50-day moving average for KMDA moved above the 200-day moving average on September 24, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
KMDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.655) is normal, around the industry mean (10.407). P/E Ratio (20.342) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.644) is also within normal values, averaging (2.152). Dividend Yield (0.088) settles around the average of (0.037) among similar stocks. P/S Ratio (2.487) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. KMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
SIGA sees MACD Histogram just turned negative
SIGA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 08, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 41 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SIGA as a result. In 74 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
SIGA moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SIGA crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 57 cases where SIGA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SIGA advanced for three days, in 234 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
SIGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 140 of 174 cases where SIGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.369) is normal, around the industry mean (10.407). P/E Ratio (-105.000) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.152). SIGA's Dividend Yield (0.762) is considerably higher than the industry average of (0.037). P/S Ratio (4.161) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. SIGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
KMDA | SIGA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 91 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 46 | 100 | |
SMR RATING 1..100 | 76 | 91 | |
PRICE GROWTH RATING 1..100 | 53 | 74 | |
P/E GROWTH RATING 1..100 | 46 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIGA's Valuation (1) in the Pharmaceuticals Other industry is in the same range as KMDA (6) in the Biotechnology industry. This means that SIGA’s stock grew similarly to KMDA’s over the last 12 months.
KMDA's Profit vs Risk Rating (46) in the Biotechnology industry is somewhat better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that KMDA’s stock grew somewhat faster than SIGA’s over the last 12 months.
KMDA's SMR Rating (76) in the Biotechnology industry is in the same range as SIGA (91) in the Pharmaceuticals Other industry. This means that KMDA’s stock grew similarly to SIGA’s over the last 12 months.
KMDA's Price Growth Rating (53) in the Biotechnology industry is in the same range as SIGA (74) in the Pharmaceuticals Other industry. This means that KMDA’s stock grew similarly to SIGA’s over the last 12 months.
KMDA's P/E Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for SIGA (100) in the Pharmaceuticals Other industry. This means that KMDA’s stock grew somewhat faster than SIGA’s over the last 12 months.
| KMDA | SIGA | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 63% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 63% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 65% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 65% | 1 day ago 80% |
| Advances ODDS (%) | N/A | 9 days ago 80% |
| Declines ODDS (%) | 1 day ago 62% | 5 days ago 75% |
| BollingerBands ODDS (%) | 1 day ago 73% | 1 day ago 69% |
| Aroon ODDS (%) | 1 day ago 62% | 1 day ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KMDA’s FA Score shows that 1 FA rating(s) are green while SIGA’s FA Score has 1 green FA rating(s).
- KMDA’s FA Score: 1 green, 4 red.
- SIGA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KMDA’s TA Score shows that 3 TA indicator(s) are bullish while SIGA’s TA Score has 4 bullish TA indicator(s).
- KMDA’s TA Score: 3 bullish, 6 bearish.
- SIGA’s TA Score: 4 bullish, 5 bearish.
Price Growth
KMDA (@Pharmaceuticals: Generic) experienced а -1.28% price change this week, while SIGA (@Pharmaceuticals: Generic) price change was -1.25% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.00%. For the same industry, the average monthly price growth was -9.86%, and the average quarterly price growth was +9.31%.
Reported Earning Dates
KMDA is expected to report earnings on Nov 09, 2026.
SIGA is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.00% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
KMDA and
Correlation & Price change
A.I.dvisor tells us that KMDA and TEVA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and TEVA's prices will move in lockstep.
| Ticker / NAME | Correlation To KMDA | 1D Price Change % | ||
|---|---|---|---|---|
| KMDA | 100% | -0.64% | ||
| TEVA - KMDA | 25% Poorly correlated | -1.01% | ||
| CRDL - KMDA | 25% Poorly correlated | -1.71% | ||
| INM - KMDA | 25% Poorly correlated | -3.62% | ||
| SIGA - KMDA | 25% Poorly correlated | +0.96% | ||
| OGI - KMDA | 25% Poorly correlated | -0.43% | ||
More | ||||
SIGA and
Correlation & Price change
A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.
| Ticker / NAME | Correlation To SIGA | 1D Price Change % | ||
|---|---|---|---|---|
| SIGA | 100% | +0.96% | ||
| EBS - SIGA | 33% Poorly correlated | +0.48% | ||
| ETON - SIGA | 30% Poorly correlated | +1.46% | ||
| AYTU - SIGA | 28% Poorly correlated | +1.02% | ||
| AMRX - SIGA | 27% Poorly correlated | +1.39% | ||
| SBFM - SIGA | 25% Poorly correlated | -22.47% | ||
More | ||||